A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-11
DOI
10.1038/s41467-021-27853-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going?
- (2020) Chiara F Magnani et al. Cells
- B-cell maturation antigen expression across hematologic cancers: a systematic literature review
- (2020) Ahmet Dogan et al. Blood Cancer Journal
- Effects of B cell–activating factor on tumor immunity
- (2020) Mark Yarchoan et al. JCI Insight
- Engineering and Design of Chimeric Antigen Receptors
- (2019) Sonia Guedan et al. Molecular Therapy-Methods & Clinical Development
- CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
- (2019) Mohamad Hamieh et al. NATURE
- Combination therapy for treating advanced drug-resistant acute lymphoblastic leukemia
- (2019) Yorleny Vicioso et al. Cancer Immunology Research
- Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen
- (2019) Marijke Timmers et al. Frontiers in Immunology
- Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR
- (2019) Sara Ghorashian et al. NATURE MEDICINE
- CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies
- (2019) Hong Qin et al. Science Translational Medicine
- The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells
- (2019) Hannah E. Hughes-Parry et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Advances in the use of natural receptor- or ligand-based chimeric antigen receptors (CARs) in haematologic malignancies
- (2018) Joana M. Murad et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Antigen Escape from CAR T-cell Therapy
- (2018) Robbie G. Majzner et al. Cancer Discovery
- Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
- (2018) Keisuke Watanabe et al. Frontiers in Immunology
- BAFF and BAFF-Receptor in B Cell Selection and Survival
- (2018) Cristian R. Smulski et al. Frontiers in Immunology
- Chimeric antigen receptor T-cell therapies for lymphoma
- (2017) Jennifer N. Brudno et al. Nature Reviews Clinical Oncology
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- BBMerge – Accurate paired shotgun read merging via overlap
- (2017) Brian Bushnell et al. PLoS One
- T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma
- (2016) S. A. Ali et al. BLOOD
- Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy
- (2016) R. Gardner et al. BLOOD
- Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
- (2016) Partow Kebriaei et al. JOURNAL OF CLINICAL INVESTIGATION
- Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
- (2016) Marco Ruella et al. JOURNAL OF CLINICAL INVESTIGATION
- Genome-wide Profiling Reveals Remarkable Parallels Between Insertion Site Selection Properties of the MLV Retrovirus and the piggyBac Transposon in Primary Human CD4+ T Cells
- (2016) Andreas Gogol-Döring et al. MOLECULAR THERAPY
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells
- (2015) Andrew G. Evans et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chimeric Antigen Receptor Engineering: A Right Step in the Evolution of Adoptive Cellular Immunotherapy
- (2015) Jose A. Figueroa et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
- (2015) E. Sotillo et al. Cancer Discovery
- B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia
- (2015) Michal Rihacek et al. Biomed Research International
- The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity
- (2014) Franziska S. Hoffmann et al. JOURNAL OF IMMUNOLOGY
- Effector-Mediated Eradication of Precursor B Acute Lymphoblastic Leukemia with a Novel Fc-Engineered Monoclonal Antibody Targeting the BAFF-R
- (2014) R. Parameswaran et al. MOLECULAR CANCER THERAPEUTICS
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors
- (2013) James N. Kochenderfer et al. Nature Reviews Clinical Oncology
- Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival
- (2012) Eric Sanchez et al. BRITISH JOURNAL OF HAEMATOLOGY
- Fast gapped-read alignment with Bowtie 2
- (2012) Ben Langmead et al. NATURE METHODS
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Pybedtools: a flexible Python library for manipulating genomic datasets and annotations
- (2011) Ryan K. Dale et al. BIOINFORMATICS
- BAFF-R expression correlates with positive selection of immature B cells
- (2011) Roxane Tussiwand et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Aberrant Expression of Functional BAFF-System Receptors by Malignant B-Cell Precursors Impacts Leukemia Cell Survival
- (2011) Sara Maia et al. PLoS One
- A Functional Receptor for B-Cell–Activating Factor Is Expressed on Human Acute Lymphoblastic Leukemias
- (2010) Reshmi Parameswaran et al. CANCER RESEARCH
- Targeting BAFF in autoimmunity
- (2010) Anne Davidson CURRENT OPINION IN IMMUNOLOGY
- HIV integration site distributions in resting and activated CD4+ T cells infected in culture
- (2009) Troy Brady et al. AIDS
- Differential Cellular Internalization of Anti-CD19 and -CD22 Immunotoxins Results in Different Cytotoxic Activity
- (2008) X. Du et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now